세계 맞춤형 의료 시장 규모는 2022년 5,120억 달러로 2023년 5,703억 7,000만 달러에서 2031년까지 1조 3,528억 1,000만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 11.40%의 CAGR을 기록할 것으로 예상됩니다.
세계 맞춤형 의료 시장은 환자 개개인에게 맞춤화된 치료를 제공하기 위한 유전자 기술의 통합에 의해 주도되고 있습니다. 인간 유전체는 각각 고유하기 때문에 맞춤형 의료는 특히 암에 대한 특정 진단과 치료를 제공하는 것을 목표로 하고 있습니다. 종양학이 여전히 주요 초점이지만, 유전자 기술의 가용성이 증가함에 따라 비종양학 응용 분야에 대한 수요도 증가하고 있습니다. 유전자 기술은 두 자릿수 성장률을 기록하고 있으며, 투자 증가로 인해 발전이 가속화되고 있습니다. 이는 알츠하이머병, 파킨슨병과 같은 희귀 질환을 치료할 수 있는 맞춤형 의료의 새로운 가능성을 열어주고 있습니다. 헬스케어 분야에서의 도입은 역사적으로 늦었지만, 의료 예산의 증가와 제약회사와 정부 기관과의 협력 강화로 인해 향후 몇 년 동안 맞춤형 의료의 도입이 가속화될 것으로 예상됩니다.
Global Personalized Medicine Market size was valued at USD 512 billion in 2022 and is poised to grow from USD 570.37 billion in 2023 to USD 1352.81 billion by 2031, growing at a CAGR of 11.40% during the forecast period (2024-2031).
The global Personalized Medicines Market is driven by the integration of genetic technology to deliver tailored treatments for individual patients. As each human genome is unique, personalized medicine aims to provide specific diagnoses and treatments, particularly for cancer. While oncology remains a major focus, the rising availability of genetic technology is spurring demand for non-oncology applications as well. Genetic technology is experiencing double-digit growth, with increasing investment propelling advancements. This has opened new possibilities for personalized medicine in treating rare diseases, including Alzheimer's and Parkinson's. Despite the historically slow adoption in healthcare, growing healthcare budgets and increased collaborations between pharmaceutical companies and government agencies are expected to accelerate the adoption of personalized medicine in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Personalized Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Personalized Medicine Market Segmental Analysis
Global Personalized Medicine Market is segmented by Product, Application, End Users, and region. Based on Product, the market is segmented into Personalized Medicine Testing (Genetic Testing, DTC Testing, Others), Personalized Medicine Therapeutics (Pharmaceuticals, Medical Devices, Others), Personalized Medical Care (Telemedicine, Health Information Technology), Personalized Nutrition & Wellness (Retail Nutrition, Complementary & Alternative Medicine). Based on Application, the market is segmented into Oncology, Neurology, Cardiology, Antiviral, Psychiatry, Immunology, and Others. Based on End Users, the market is segmented into Hospitals And Clinical Care, Diagnostic Companies and Testing Facilities, Academic Research Institutes and Research Laboratories, Contract Research Organizations, Bio and Health Informatics Companies, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Personalized Medicine Market
The rapid advancement of genetic technology is significantly influencing the healthcare and pharmaceutical industries, driving the demand for personalized medicines. With the genetic technology market valued at over USD 5 billion and anticipated to grow at a compound annual growth rate (CAGR) of more than 20% throughout the forecast period, the sector is attracting increasing investments. This growth is expected to enhance the availability, accessibility, and demand for personalized medicines, paving the way for more tailored and effective treatments. As genetic innovations continue to evolve, the integration of these technologies into personalized medicine is set to revolutionize healthcare delivery, further accelerating market expansion.
Restraints in the Global Personalized Medicine Market
One of the key restraints for the global Personalized Medicines Market is the slow adoption of new technologies within the healthcare industry. The sector is typically conservative in integrating advanced innovations like AI and genetic engineering, largely due to stringent regulations. Regulatory bodies impose strict guidelines on the use of these technologies in healthcare applications, and authorities are often hesitant to approve their widespread adoption until they are fully confident in their safety and effectiveness. This cautious approach significantly delays the implementation of cutting-edge technologies in personalized medicine, hindering market growth and innovation in the field.
Market Trends of the Global Personalized Medicine Market
A significant trend in the global Personalized Medicines Market is the increase in healthcare budgets across both developed and developing economies, a shift that has gained momentum in the post-pandemic era. While stagnant healthcare budgets had been a concern for many years, governments have notably boosted funding for healthcare, which is directly fueling research and development (R&D) in alternative treatments and personalized medicines. This rise in healthcare expenditure is improving access to personalized medicine for patients who require tailored treatments and can afford them, thereby driving market growth and expanding patient access to innovative therapeutic options.